For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain. On January 31, the FDA approved Journavx as a non-opioid treatment for ...

New synthetic opioids (NSOs) are one of the fastest-growing groups of new psychoactive substances around the world ...

While overdose rates have dropped amongst the middle-class, especially casual recreational users, the drug supply has become ...

The opioid crisis in 2023, amid the Biden administration, cost the U.S. $2.7 trillion, according to a Council of Economic ...

Two South African harm reduction sites are among the many casualties. “I owe my HIV-negative status to their efforts,” says a ...

The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.

Veterans who were simultaneously prescribed opioids and benzodiazepines by the Veterans Health Administration (VHA) faced an ...

Ahead of this weekend's Super Bowl, some good news for the athletes: NFL players are largely avoiding opioid-based pain ...

A binding rule published in the final days of the Biden administration changes the way providers prescribe medications for ...

Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...

The approach to bring those numbers down has been all hands on deck. While statistics show it's working, overdose deaths are rising at alarming rates among Black communities.

Lawmakers rallied around the HALT Fentanyl Act on Thursday, successfully passing the legislation in the House to classify the ...